Medycyna Wieku Rozwojowego

Próba leczenia zachowawczego u pacjentów z jednoczesnà postacià retinoblastoma
4. Scott I.U., Murray T.G., Toledano S., O’Brien J.M.: New retinoblastoma tumors in children
undergoing chemotherapy. Arch. Ophthalmol., 1998, 116, 12, 1685-1686.
5. Shields C.L., Shields J.A., Wagner R.: Eye to Eye: Retinoblastoma. J. Ped. Ophthalmol.
Strabism., 2003, 40, 1, 6-8.
6. Pratt C.B.: Use of chemotherapy for retinoblastoma. Med. Pediatr. Oncol., 1998, 31, 531-
-533.
7. Shields C.L., Shields J.A.: Chemotherapy for retinoblastoma. Med. Pediatr. Oncol., 2002,
38, 6, 377-378.
8. Rodriquez-Galindo C., Wilson M.W., Haik G.B., Merchant T.E. i wsp.: Treatment of intraocular
retinoblastoma with vincristine and carboplatin. J. Clin. Oncol., 2003, 21, 2019-2025.
9. Bellaton E., Bertozzi A.I., Behar C., Chastagner P. i wsp.: Neoadjuvant chemotherapy for
extensive unilateral retinoblastoma. Br. J. Ophthalmol., 2003, 87, 327-329.
10. Gombos D.S., Kelly A., Coen P.G., Kingston J.E., Hungerford J.L.: Retinoblastoma treated
with primary chemotherapy alone: the siginificance of tumour size, location, and age. Br. J.
Ophthalmol., 2003, 86, 80-83.
11. Shields C.L., Mashayeki A., Cater J., Shelil A. i wsp.: Macular retinoblastoma managed
with chemoreduction: analysis of tumor control with or wthout adjuvant thermotherapy in 68
tumors. Arch. Ophthalmol., 2005, 123, 6, 765-773.
12. Shields C.L., Honavar S.G., Shields J.A., Demirci H. i wsp.: Factors predictive of reccurence
of retinal tumors, vitreous seed, and subretinal seeds following chemoreduction for retinoblastoma.
Arch. Ophthalmol., 2002, 120, 4, 460-466.
13. Shields C.L., Shelil A., Cater J., Shields J.A., Meadows A.: Development of new retionblastomas
after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive
patients. Arch. Ophthalmol., 2003, 121, 11, 1571-1576.
14. Hadjistilianou T., Mastrangelo D., De Francesco S., Mazzotta C.: Conservative treatment
in unilateral retinoblastoma: a prelimiminary report. Med. Pediatr. Oncol., 2002, 38, 6, 442-444.
15. Gunduz K., Shields C.L., Shields J.A., Meadows A.T. i wsp.: The outcome of chemoreductio
treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch. Ophthalmol.,
1998, 116, 12, 1613-1617.
16. Shields C.L., Mashayekhi A., Demirci H., Meadows A.T., Shields J.A.: Practical approach
to management of retinoblastoma. Arch. Ophthalmol., 2004, 122, 5, 729-735.
Olga Rutynowska-Pronicka
Klinika Onkologii
Instytut „Pomnik – Centrum
Zdrowia Dziecka” w Warszawie
Al. Dzieci Polskich 20,
04-730 Warszawa
Tel.: 0-22 815 17 74, 0-22 815 17 87
e-mail: o.rutynowska@czd.pl
663